Raj Denhoy
Stock Analyst at Jefferies
(1.91)
# 1,805
Out of 4,667 analysts
55
Total ratings
68.89%
Success rate
24.08%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $115.93 | +3.51% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $69.54 | +86.94% | 10 | Jul 30, 2021 | |
| HOLX Hologic | Maintains: Buy | $106 → $110 | $78.04 | +40.95% | 9 | Apr 5, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $7.69 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $75.24 | -58.47% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $12.90 | +171.32% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $187.43 | +57.39% | 9 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $86.45 | -68.77% | 2 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $50.05 | +81.82% | 3 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $266.58 | -74.87% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $115.93
Upside: +3.51%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $69.54
Upside: +86.94%
Hologic
Apr 5, 2021
Maintains: Buy
Price Target: $106 → $110
Current: $78.04
Upside: +40.95%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $7.69
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $75.24
Upside: -58.47%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $12.90
Upside: +171.32%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $187.43
Upside: +57.39%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $86.45
Upside: -68.77%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $50.05
Upside: +81.82%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $266.58
Upside: -74.87%